Development
abrdn Healthcare Opportunities Fund
THQ
$16.70
$0.432.64%
| Weiss Ratings | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | abrdn Inc. | |||
| Manager/Tenure (Years) | Jason C. Akus (1) | |||
| Website | http://www.abrdn.com/us | |||
| Fund Information | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | abrdn Healthcare Opportunities Fund | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jul 28, 2014 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.86% | |||
| Asset Allocation | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.36% | |||
| Stock | 83.58% | |||
| U.S. Stock | 82.81% | |||
| Non-U.S. Stock | 0.77% | |||
| Bond | 14.02% | |||
| U.S. Bond | 13.53% | |||
| Non-U.S. Bond | 0.49% | |||
| Preferred | 2.04% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -11.45% | |||
| 30-Day Total Return | -14.05% | |||
| 60-Day Total Return | -13.55% | |||
| 90-Day Total Return | -7.69% | |||
| Year to Date Total Return | -7.69% | |||
| 1-Year Total Return | -8.67% | |||
| 2-Year Total Return | 1.11% | |||
| 3-Year Total Return | -6.25% | |||
| 5-Year Total Return | 48.63% | |||
| Price | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | $20.18 | |||
| 1-Month High Price | $21.08 | |||
| 52-Week Low Price | $18.42 | |||
| 52-Week Low Price (Date) | Dec 19, 2024 | |||
| 52-Week High Price | $22.58 | |||
| 52-Week High Price (Date) | Oct 14, 2024 | |||
| NAV | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $19.94 | |||
| 1-Month Low NAV | $19.94 | |||
| 1-Month High NAV | $21.07 | |||
| 52-Week Low NAV | $19.83 | |||
| 52-Week Low NAV (Date) | Dec 19, 2024 | |||
| 52-Week High NAV | $23.43 | |||
| 52-Week High Price (Date) | Sep 16, 2024 | |||
| Beta / Standard Deviation | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Standard Deviation | 14.69 | |||
| Balance Sheet | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 838.60M | |||
| Operating Ratios | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.47% | |||
| Turnover Ratio | 43.00% | |||
| Performance | THQ-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 7.85% | |||
| Last Bear Market Total Return | -8.49% | |||